Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Nephrology
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Study protocol

Prevalence and correlates of non-adherence to immunosuppressants and to health behaviours in patients after kidney transplantation in Brazil – the ADHERE BRAZIL multicentre study: a cross-sectional study protocol

Authors: Helady Sanders-Pinheiro, Fernando Antonio Basile Colugnati, Elisa Oliveira Marsicano, Sabina De Geest, José Osmar Pestana Medina, on behalf of Adhere Brazil Consortium Group

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Non-adherence to immunosuppressive therapy is a prevalent risk factor for poor clinical and after kidney transplantation (KT), and has contributed to the lack of improvement in long-term graft survival over the past decade. Understanding the multilevel correlates and risk factors of non-adherence is crucial to determine the optimal level for planning interventions, namely at the patient, health care provider, KT centre, and health care system level. Brazil, having the largest public transplantation program in the world and with regional differences regarding access to health services and service implementation, is in a unique position to study this multilevel approach. Therefore, the Adhere Brazil Study (ADHERE BRAZIL) was designed to assess the prevalence and variability of non-adherence to immunosuppressants and to health behaviours among adult KT recipients in Brazil, and to assess the multilevel correlates of non-adherence to immunosuppressive medication. We describe the rationale, design, and methodology of the ADHERE BRAZIL study.

Methods/Design

This is an observational, cross-sectional, multicentre study that includes 20 Brazilian KT centres. A stratified sampling approach is used, based on strata, with the following characteristics considered: geographical region and transplant activity (number of KTs per year). A random sample of patients (proportional to the size of the centre within each stratum) is selected from each centre. The prevalence of different health behaviours is assessed through self-report. The assessment of multilevel correlates of non-adherence is guided by the ecological model that considers factors at the level of the patient, health-care professional, and transplant centre, using established instruments or instruments developed for this study. Data will be collected over an 18-month period, with information obtained during the regular follow-up visits to the transplant outpatient clinic and directly entered into the Research Electronic Data Capture (RedCap) system. Data entry is performed by a trained professional who is part of the transplant team. The data collection began in December 2015.

Discussion

This multicentre study is the first to evaluate multilevel correlates of non-adherence in KT patients and will provide a reliable estimate of non-adherence in Brazilian KT patients.

Trial registration

ClinicalTrials.gov on 10/10/2013, NCT02066935.
Appendix
Available only for authorised users
Literature
1.
Meier-Kriesche HU, Ojo AO, Port FK, Arndorfer JA, Cibrik DM, Kaplan B. Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol. 2001;12(6):1293–6.PubMed
2.
3.
Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2011;11(3):450–62.CrossRefPubMed
4.
Lodhi SA, Lamb KE, Meier-Kriesche HU. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant. 2011;11(6):1226–35.CrossRefPubMed
5.
Denhaerynck K, Dobbels F, Cleemput I, Desmyttere A, Schäfer-Keller P, Schaub S, De Geest S. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transpl Int. 2005;18(10):1121–33.CrossRefPubMed
6.
Prendergast MB, Gaston RS. Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation. Clin J Am Soc Nephrol. 2010;5:1305–11.CrossRefPubMedPubMedCentral
7.
Nankivell BJ, Kuypers DR. Diagnosis and prevention of chronic kidney allograft loss. Lancet. 2011;378(9800):1428–37.CrossRefPubMed
8.
De Geest S, Denhaerynck K, Dobbels F. Clinical and economic consequences of non-adherence to immunosuppressive drugs in adult solid organ transplantation. Compliance in solid organ transplantation (Invited Editor: Dr. Federico Oppenheimer), included in the series International Transplantation Updates, (editor in Chief: Dr. JM Grinyó). Barcelona: Permanyer Publications; 2011. p. 63:81.
9.
Berben L, Dobbels F, Engberg S, Hill MN, De Geest S. An ecological perspective on medication adherence. Western J Nurs Res. 2012;34:635–53.CrossRef
10.
Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
11.
Dew MA, DiMartini AF, De Vito Dabbs A, Myaskovsky L, Steel J, Unruh M, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83(7):858–73.CrossRefPubMed
12.
Bronfenbrenner U. Toward an experimental ecology of human development. Am Psychol. 1977;32(7):513–31.CrossRef
13.
Nuno R, Coleman K, Bengoa R, Sauto R. Integrated care for chronic conditions: the contribution of the ICCC framework. Health Policy. 2012;105(1):55–64.CrossRefPubMed
14.
Bissonnette J, Woodend K, Davies B, Stacey D, Knoll GA. Evaluation of a collaborative chronic care approach to improve outcomes in kidney transplant recipients. Clin Transpl. 2013;27(2):232–8.CrossRef
15.
Schmid A, Hils S, Kramer-Zucker A, Bogatyreva L, Hauschke D, De Geest S, Pisarski. Telemedically supported case management of living-donor renal transplant recipients to optimize routine evidence-based aftercare: a single-center randomized controlled trial. Am J Transplant. 2016; https://​doi.​org/​10.​1111/​ajt.​14138. [Epub ahead of print]
16.
De Geest S, Dobbels F, Gordon E, De Simone P. Chronic illness management as an innovative pathway for enhancing long-term survival in transplantation. Am J Transplant. 2011;11(10):2262–3.CrossRefPubMed
17.
Ronco C, Mason G, Nayak Karopadi A, Milburn A, Hegbrant J. Healthcare systems and chronic kidney disease: putting the patient in control. Nephrol Dial Transplant. 2014;29(5):958–63.CrossRefPubMed
18.
Berben L, Denhaerynck K, Dobbels F, Engberg S, Vanhaecke J, Crespo-Leiro MG, et al. BRIGHT study consortium. Building research initiative group: chronic illness management and adherence in transplantation (BRIGHT) study: study protocol. J Adv Nurs. 2015;71(3):642–54.CrossRefPubMed
19.
Cajita MI, Denhaerynck K, Dobbels F, Berben L, Russell CL, Davidson PM, et al. BRIGHT study team. Health literacy in heart transplantation: Prevalence, correlates and associations with health behaviors-findings from the international BRIGHT study. J Heart Lung Transplant. 2016; https://​doi.​org/​10.​1016/​j.​healun.​2016.​08.​024. Epub ahead of print
20.
21.
Fine RN, Becker Y, De Geest S, Eisen H, Ettenger R, Evans R, Rudow DL, McKay D, Neu A, Nevins T, Reyes J, Wray J, Dobbels F. Nonadherence consensus conference summary report. Am J Transplant. 2009;9(1):35–41.CrossRefPubMed
22.
Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation. 2004;77(5):769–76.CrossRefPubMed
23.
Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant. 2009;9(11):2597–606.CrossRefPubMed
24.
Sellarés J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant. 2012;12(2):388–99.CrossRefPubMed
25.
Wiebe C, Gibson IW, Blydt-Hansen TD, Karpinski M, Ho J, Storsley LJ, et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant. 2012;12(5):1157–67.CrossRefPubMed
26.
Spivey CA, Chisholm-Burns MA, Damadzadeh B, Billheimer D. Determining the effect of immunosuppressant adherence on graft failure risk among renal transplant recipients. Clin Transpl. 2014;28(1):96–104.CrossRef
27.
Osterberg LB. Drug therapy: adherence to medication. N Engl Med. 2005;353(5):487–97.CrossRef
28.
Dobbels F, Lut B, De Geest S, Drent G, Lennerling A, Whittaker C, et al. The psychometric properties and practicability of self-report instruments to identify medication non-adherence in adult transplant patients to date: a systematic review. Transplantation. 2010;90(2):205–19.CrossRefPubMed
29.
Schäfer-Keller P, Steiger J, Bock A, Denhaerynck K, De Geest S. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant. 2008;8(3):616–26.CrossRefPubMed
30.
Duerinckx N, Burkhalter H, Engberg SJ, Kirsch M, Klem ML, Sereika SM, et al. B-SERIOUS consortium: Correlates and outcomes of posttransplant smoking in solid organ transplant recipients: a systematic literature review and meta-analysis. Transplantation. 2016;100(11):2252–63.CrossRefPubMed
31.
Gueye AS, Chelamcharla M, Baird BC, Nguyen C, Tang H, Barenbaum AL, et al. The association between recipient alcohol dependency and long-term graft and recipient survival. Nephrol Dial Transplant. 2007;22(3):891–8.CrossRefPubMed
32.
Zelle DM, Agarwal PK, Ramirez JL, van der Heide JJ, Corpeleijn E, et al. Alcohol consumption, new onset of diabetes after transplantation, and all-cause mortality in renal transplant recipients. Transplantation. 2011;92(2):203–9.CrossRefPubMed
33.
Gordon EJ, Prohaska TR, Gallant MP, Sehgal AR, Strogatz D, Conti D, et al. Prevalence and determinants of physical activity and fluid intake in kidney transplant recipients. Clin Transpl. 2010;24(3):E69–81.CrossRef
34.
Bellizzi V, Cupisti A, Capitanini A, Calella P, D'Alessandro C. Physical activity and renal transplantation. Kidney Blood Press Res. 2014;39(2-3):212–9.CrossRefPubMed
35.
Macdonald JH, Kirkman D, Jibani M. Kidney transplantation: a systematic review of interventional and observational studies of physical activity on intermediate outcomes. Adv Chronic Kidney Dis. 2009;16(6):482–500.CrossRefPubMed
36.
Medina-Pestana JO, Galante NZ, Tedesco-Silva H Jr, Harada KM, Garcia VD, Abbud-Filho M, et al. Kidney transplantation in Brazil and its geographic disparity. J Bras Nefrol. 2011;33(4):472–84.CrossRefPubMed
37.
Silva HT Jr, Felipe CR, Abbud-Filho M, Garcia V, Medina-Pestana JO. The emerging role of Brazil in clinical trial conduct for transplantation. Am J Transplant. 2011;11(7):1368–75.CrossRefPubMed
38.
Costa CK, Balbinotto Neto G, Sampaio LM. Efficiency of Brazilian States and the Federal District in the public kidney transplant system based on DEA (data envelopment analysis) and the Malmquist index. Cad Saude Publica. 2014;30(8):1667–79.CrossRefPubMed
39.
Viacava F, Bellido JG. Health, access to services and sources of payment, according to household surveys. Cien Saude Colet. 2016;21(2):351–70.CrossRefPubMed
40.
Bittar AE, Keitel E, Garcia CD, Bruno RM, Silveira AE, Messias A, et al. Patient noncompliance as a cause of late kidney graft failure. Transplant Proc. 1992;24(6):2720–1.PubMed
41.
Michelon TF, Piovesan F, Pozza R, Castilho C, Bittar AE, Keitel E, et al. Noncompliance as a cause of renal graft loss. Transplant Proc. 2002;34:2768–70.CrossRefPubMed
42.
Brahm MM, Manfro RC, Mello D, Cioato S, Gonçalves LF. Evaluation of adherence to immunosuppressive drugs in kidney transplantation by control of medication dispensing. Transplant Proc. 2012;44(8):2391–3.CrossRefPubMed
43.
Marsicano Ede O, Fernandes Nda S, Colugnati F, Grincenkov FR, Fernandes NM, De Geest S, et al. Transcultural adaptation and initial validation of Brazilian-Portuguese version of the Basel assessment of adherence to immunosuppressive medications scale (BAASIS) in kidney transplants. BMC Nephrol. 2013;14:108.CrossRefPubMed
44.
Garcia MF, Bravin AM, Garcia PD, Contti MM, Nga HS, Takase HM, et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. Int Urol Nephrol. 2015;47(11):1899–905.CrossRefPubMed
45.
Silva AN, Moratelli L, Tavares PL, de Oliveira Marsicano E, Pinhati RR, Colugnati FA, et al. Self-efficacy beliefs, locus of control, religiosity and non-adherence to immunosuppressive medications in kidney transplant patients. Nephrology (Carlton). 2015; https://​doi.​org/​10.​1111/​nep.​12695.
46.
Brito DC, Marsicano EO, Grincenkov FR, Colugnati FA, Lucchetti G, Sanders-Pinheiro H. Stress, coping and adherence to immunosuppressive medications in kidney transplantation: a comparative study. Sao Paulo Med J. 2016;134(4):292–9.CrossRefPubMed
47.
Bessa AB, Felipe CR, Hannun P, Sayuri P, Felix MJ, Ruppel P, et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Ther Drug Monit. 2016;38(4):447–55.PubMed
48.
49.
50.
Yach D. Innovative care for chronic conditions–building blocks for action. Geneva: World Health Organization; 2002.
51.
Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.CrossRefPubMedPubMedCentral
52.
Denhaerynck K, Burkhalter F, SchäferKeller P, Steiger J, Bock A, De Geest S. Clinical consequences of non adherence to immunosuppressive medication in kidney transplant patients. Transpl Int. 2009;22:441–6.CrossRefPubMed
53.
De Bleser L, Dobbels F, Berben L, Vanhaecke J, Verleden G, Nevens F, et al. The spectrum of nonadherence with medication in heart, liver, and lung transplant patients assessed in various ways. Transpl Int. 2011;24(9):882–91.CrossRefPubMed
54.
Marshall AL, Smith BJ, Bauman AE, Kaur S. Reliability and validity of a brief physical activity assessment for use by family doctors. Br J Sports Med. 2005;39(5):294–7.CrossRefPubMedPubMedCentral
55.
56.
Fiore M, Jaen CR, Baker TB. Treating tobacco use and dependence: 2008 update. Rockville: U.S. Department of Health and Human Services; 2008.
57.
World Health Organization – WHO. Global status report on alcohol. Genebra: WHO; 2004.
58.
Russell CL, Kilburn E, Conn VS, Libbus MK, Ashbaugh C. Medication-taking beliefs of adult renal transplant recipients. Clin Nurse Spec. 2003;17(4):200–8.CrossRefPubMed
59.
Butler JA, Peveler RC, Roderick P, Smith PW, Horne R, Mason JC. Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study. Nephrol Dial Transplant. 2004;19(12):3144–9.CrossRefPubMed
60.
Denhaerynck K, Steiger J, Bock A, Schäfer-Keller P, Köfer S, Thannberger N, et al. Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. Am J Transplant. 2007;7(1):108–16.CrossRefPubMed
61.
Prihodova L, Nagyova I, Rosenberger J, Majernikova M, Roland R, Groothoff JW, et al. Adherence in patients in the first year after kidney transplantation and its impact on graft loss and mortality: a cross-sectional and prospective study. J Adv Nurs. 2014;70(12):2871–83.CrossRefPubMed
62.
Vlaminck H, Maes B, Evers G, Verbeke G, Lerut E, Van Damme B, et al. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant. 2004;4(9):1509–13.CrossRefPubMed
63.
64.
65.
66.
World Health Organization. Preparing a health care workforce for the 21st century: the challenge of chronic conditions. Geneva: World Health Organization; 2005.
67.
Berben L, Russell CL, Engberg S, Dobbels F, De Geest S. Development, content validity and inter-rater reliability testing of the chronic illness management implementation – building research initiative group: chronic illness management and adherence in transplantation: an instrument to assess the level of chronic illness management implemented in solid organ transplant programmes. Intern J Care. 2014;17(1–2):59–71.
68.
Melchior R, Nemes MI, Basso CR, Castanheira ER, Alves MT, Buchalla CM, et al. Evaluation of the organizational structure of HIV/AIDS outpatient care in Brazil. Rev Saude Publica. 2006;40(1):143–51.CrossRefPubMed
69.
BRASIL, Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de DST e AIDS. Avaliação da qualidade da assistência ambulatorial nos serviços públicos de atenção à AIDS no Brasil - Sistema de Avaliação QualiAIDS. Departamento de DST, Aids e Hepatites Virais, Equipe de Pesquisa QualiAIDS, Departamento de Medicina Preventiva, Faculdade de Medicina, Universidade de São Paulo. 2006. Available: http://​bvsms.​saude.​gov.​br/​bvs/​publicacoes/​caderno_​qualiaids.​pdf. Accessed 10 Mar 2017.
70.
Victora CG, Huttly SR, Fuchs SC, Olinto MT. The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. Int J Epidemiol. 1997;26(1):224–7.CrossRefPubMed
71.
Wasserstein RL, Lazar NA. The ASA’s statement on p-values: context, process, and purpose. Am Stat. 2016;70(2):129–33.CrossRef
Metadata
Title
Prevalence and correlates of non-adherence to immunosuppressants and to health behaviours in patients after kidney transplantation in Brazil – the ADHERE BRAZIL multicentre study: a cross-sectional study protocol
Authors
Helady Sanders-Pinheiro
Fernando Antonio Basile Colugnati
Elisa Oliveira Marsicano
Sabina De Geest
José Osmar Pestana Medina
on behalf of Adhere Brazil Consortium Group
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-0840-6

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue

Case report

Intravascular lymphoma forming massive aortic tumors complicated with sarcoidosis and focal segmental glomerulosclerosis: a case report and literature review

Research article

Association of arterial stiffness and central hemodynamics with moderately reduced glomerular filtration rate in Chinese middle-aged and elderly community residents: a cross-sectional analysis

Research article

Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea

Research article

Cancer risk after renal transplantation in South Korea: a nationwide population-based study

Research article

Safety and effectiveness of low-protein diet supplemented with ketoacids in diabetic patients with chronic kidney disease

Case report

Star fruit nephrotoxicity: a case series and literature review

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits